Picture of Basilea Pharmaceutica AG, Allschwil logo

BSLN — Basilea Pharmaceutica AG, Allschwil News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Basilea Pharmaceutica: Cresemba Sales In Asia Pacific Trigger Milestone Payment From Pfizer

June 17 (Reuters) - BASILEA PHARMACEUTICA AG  BSLN.S :
    * CRESEMBA® SALES IN ASIA PACIFIC REGION TRIGGER SALES
MILESTONE
PAYMENT TO BASILEA FROM PFIZER
    * BASILEA PHARMACEUTICA AG -  SALES OF ANTIFUNGAL CRESEMBA
BY ITS
LICENSE PARTNER PFIZER INC. IN ASIA PACIFIC REGION EXCEEDED
THRESHOLD TRIGGERING FIRST SALES MILESTONE PAYMENT FOR THIS
REGION OF USD 1.25 MILLION

Source text for Eikon:  ID:nGNX5FPWxK 
Further company coverage:  BSLN.S 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Basilea Pharmaceutica AG, Allschwil

See all news